Color Genomics democratizes access to genetic information. The Color Test is physician-ordered and comes with complimentary board-certified genetic counseling for clients and healthcare providers. The 30-gene Color Test analyzes genes closely associated with some of the most common hereditary cancers: breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancers.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/27/16 | $45,000,000 |
Bono Emerson Collective Susan Wagner | undisclosed | |
| 08/17/17 | $80,000,000 | Series C |
CRV Emerson Collective | undisclosed |
| 11/09/21 | $100,000,000 | Series E |
Emerson Collective Kindred Ventures  T. Rowe Price Associates Viking Global Investors | $4,600,000,000 |
